Galactin-8 DNA methylation mediates macrophage autophagy through the MAPK/mTOR pathway to alleviate atherosclerosis
- PMID: 39747459
- PMCID: PMC11695939
- DOI: 10.1038/s41598-024-85036-1
Galactin-8 DNA methylation mediates macrophage autophagy through the MAPK/mTOR pathway to alleviate atherosclerosis
Erratum in
-
Correction: Galactin-8 DNA methylation mediates macrophage autophagy through the MAPK/mTOR pathway to alleviate atherosclerosis.Sci Rep. 2025 Jul 1;15(1):20406. doi: 10.1038/s41598-025-08357-9. Sci Rep. 2025. PMID: 40596280 Free PMC article. No abstract available.
Abstract
DNA methylation modifications are an important mechanism affecting the process of atherosclerosis (AS). Previous studies have shown that Galectin-8 (GAL8) DNA methylation level is associated with sudden death of coronary heart disease or acute events of coronary heart disease. However, the mechanism of GAL8 DNA methylation and gene expression in AS has not been elucidated, prompting us to carry out further research on it. ApoE-/- mice were used to establish an atherosclerosis model, and DNA methylation inhibitor DO05 and MAPK/mTOR inhibitor UO126 were used for intervention. Pyrosequencing was used to detect changes in GAL8 DNA methylation levels of the mouse aorta between groups. ROC curve analysis was performed to assess the relationship between GAL8 DNA methylation and atherosclerosis. Aortic staining with hematoxylin and eosin (H&E) was used to observe the aortic intima, plaque area, and characteristics of secondary lesions within the plaque. Oil Red O staining was used to detect lipid deposition in mouse arterial plaques or macrophages. Movat staining was used to detect the number of foam cells in the plaque. Immunohistochemistry (IHC) and Western blot were used to quantify the localization and expression levels of DNA methyltransferase1 (DNMT1), GAL8, MAPK/mTOR pathway proteins, Light Chain3 (LC3), Beclin1, Sequestosome1 (p62), Tumor Necrosis Factor-α (TNF-α), and other proteins. Immunofluorescence (IF) was used to detect the fluorescence intensity of GAL8, LC3, Monocyte chemoattractant protein-1(MCP-1), and other proteins. Detection of autophagosomes in macrophages by transmission electron microscopy was also performed. The foam cell model was induced with human monocytes (THP-1) and co-cultured with foam cells using siRNAs targeting GAL8, DO05, and UO126. The level of DNMT1 was detected by Western blot; Oil red O staining was used to detect lipid deposition in foam cells in each group, and the localization and expression levels of GAL8, MAPK/mTOR pathway proteins, LC3, Beclin1, p62, and TNF-α were quantitatively determined by Western blot. Immunofluorescence (IF) was used to detect the fluorescence intensity of GAL8, MAPK/mTOR pathway protein, LC3, p62, TNF-α, and other proteins. The GAL-8 promoter region harbors six CpG sites susceptible to DNA methylation. Following DNMT1 inhibition, the DC05 group displayed a significant decrease in methylation across all six CpG sites compared to the C57 and AS groups. Conversely, the UO126 group exhibited increased methylation at the first three CpG loci relative to the AS group. ROC curve analysis revealed GAL8 DNA methylation as an independent risk factor for atherosclerosis: GAL8, along with inflammation-related proteins MCP-1, MMP9, and TNF-α, were upregulated in the mouse lesion group, while expression of autophagy-related proteins LC3 and Beclin1 was downregulated. Additionally, phosphorylated MAPK/mTOR pathway proteins were detected in the mouse model of atherosclerosis. After inhibiting the methylation level of GAL-8 DNA, the expression of GAL-8 was up-regulated, macrophage autophagy was inhibited, inflammation was increased, and atherosclerotic lesions in mice were aggravated. After direct inhibition of the activity of the MAPK/mTOR pathway, macrophage autophagy was further weakened, the inflammatory response was further aggravated, and the atherosclerotic lesions of mice were further aggravated. After the specific knockdown of GAL-8 using siRNA GAL-8 using foam cells, the above phenomenon was reversed, macrophage autophagy was promoted, the inflammatory response was reduced, and the degree of atherosclerosis was alleviated. The degree of GAL8 DNA methylation is related to the progression of atherosclerosis, and its hypomethylation can aggravate atherosclerotic lesions. The mechanism may be through the regulation of MAPK/mTOR pathway to slow down the autophagy of macrophages, and then aggravate the inflammation in plaques. Targeting GAL8 DNA methylation may be a new target for the diagnosis and treatment of atherosclerosis.
Keywords: GAL-8 promoter methylation; Atherosclerosis; Coronary heart disease; MAPK/mTOR signaling Pathway.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: Bing Xia, Yan-lin Lu contributed equally to this work.
Figures







Similar articles
-
miR-210 Regulates Autophagy Through the AMPK/mTOR Signaling Pathway, Reduces Neuronal Cell Death and Inflammatory Responses, and Enhances Functional Recovery Following Cerebral Hemorrhage in Mice.Neurochem Res. 2025 Jun 5;50(3):180. doi: 10.1007/s11064-025-04434-7. Neurochem Res. 2025. PMID: 40471451 Free PMC article.
-
Ertugliflozin attenuates atherosclerosis in nondiabetic ApoE-/- mice by upregulating ABCA1 and LDLR via the PPARγ/LXRα pathway.Biochim Biophys Acta Mol Basis Dis. 2025 Oct;1871(7):167927. doi: 10.1016/j.bbadis.2025.167927. Epub 2025 May 24. Biochim Biophys Acta Mol Basis Dis. 2025. PMID: 40419168
-
Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy.PLoS One. 2025 Jun 27;20(6):e0326687. doi: 10.1371/journal.pone.0326687. eCollection 2025. PLoS One. 2025. PMID: 40577270 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
Cited by
-
A Narrative Review on the Multifaceted Roles of Galectins in Host-Pathogen Interactions During Helicobacter pylori Infection.Int J Mol Sci. 2025 Jul 25;26(15):7216. doi: 10.3390/ijms26157216. Int J Mol Sci. 2025. PMID: 40806347 Free PMC article. Review.
-
Post-translational modifications orchestrate mTOR-driven cell death in cardiovascular disease.Front Cardiovasc Med. 2025 Jul 15;12:1620669. doi: 10.3389/fcvm.2025.1620669. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40734978 Free PMC article. Review.
-
MethPriorGCN: a deep learning tool for inferring DNA methylation prior knowledge and guiding personalized medicine.Brief Bioinform. 2025 Mar 4;26(2):bbaf131. doi: 10.1093/bib/bbaf131. Brief Bioinform. 2025. PMID: 40131311 Free PMC article.
-
Lactoferrin influences atherosclerotic progression by modulating macrophagic AMPK/mTOR signaling-dependent autophagy.Sci Rep. 2025 Mar 27;15(1):10585. doi: 10.1038/s41598-025-95181-w. Sci Rep. 2025. PMID: 40148507 Free PMC article.
-
mTOR Signaling in Macrophages: All Depends on the Context.Int J Mol Sci. 2025 Aug 6;26(15):7598. doi: 10.3390/ijms26157598. Int J Mol Sci. 2025. PMID: 40806725 Free PMC article. Review.
References
-
- World Health Organization. Global health estimates: leading causes of death. 2021. https://www.who.int/data/gho/data/themes/mortality. Accessed 01 Mar 2021.
-
- Robert, J. et al. Sudden cardiac death caused by coronary heart disease. Circulation125(8), 1043–1052 (2012). - PubMed
-
- Van den Hoogen, I. J. et al. What atherosclerosis findings can CT see in sudden coronary death: Plaque rupture versus plaque erosion. J. Cardiovasc. Comput. Tomogr.14(3), 214–218 (2020). - PubMed
-
- Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med.377(12), 1119–1131 (2017). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous